You are reading: Healthy Participants | The Resilience Study
Healthy Participants

The Resilience Study

Start date
Jul 14th
Remuneration
$12,825
20 nights, 1 appointment, 1 phone call

Help Test a New Treatment for B-Cell Malignancies

This clinical study is evaluating a new treatment for B-Cell Malignancies. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.
man and woman in embrace

Schedule

Cohort 1.1

20 nights

Check In
Jul 14th
Check Out
Aug 03rd
1 phone call
Aug 30th
1 appointment
Aug 09th

To Qualify, You Must

Age
Be 18 to 60 years old
Gender
Both males or females Must be a woman of non-childbearing potential
Physical Condition
Have no significant medical health conditions or allergies
Requirements
Have a BMI between 18 and 32kg/m2
Remuneration
$12,825

Help Test a New Treatment for B-Cell Malignancies

Spots are limited. Find out if you qualify today!